Novogene specializes in the application of advanced molecular biotechnology and high-performance computing in the research fields of life science and human health. Established in March 2011, Novogene strives to become a global leader in providing genetic science services and technology products. Nov...See more
Countries of operation Singapore |
Year founded 2011 (13 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
General Manager
Vice President & General Manager of AMEA region
Market Research Director
The company has corporate shareholder(s) or more than 20 individual shareholders
The company is owned by individual shareholder(s), it has no corporate shareholder.
The company has a sophisticated ownership structure and may be part of a large corporate group
Auditor: | SHINEWING LLP |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 22 Feb 2019 | Singapore | USD 620,000 | 64202: OTHER HOLDING COMPANIES |
| 2 Dec 2021 | Singapore | SGD 1 | 62021: INFORMATION TECHNOLOGY CONSULTANCY (EXCEPT CYBERSECURITY) |